Intensity Therapeutics Competitors and Similar CompaniesClear all
Acrivon's competitors and similar companies include Numab.
 Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. | ||
Founding Date | Founding Date 2018 | Founding Date 2011 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Watertown, US HQ Lund, SE | Locations Wädenswil, CH HQ |
Employees | Employees 415% increase | Employees 681% decrease |
For sources of this data, please see the company profile
View Company Profiles
Numab
HQ
Wädenswil, CH
Employees
68↓ 1% decrease
Numab Therapeutics is an oncology-focused biopharmaceutical company.
View company